摘要
凝血酶激活的纤溶抑制物(TAFI)是一种主要由肝脏合成分泌的,具有血浆羧肽酶样活性的单链糖蛋白,在血浆中以酶原的形式存在。传统的TAFI检测方法为酶联免疫吸附试验(ELISA)、酶学测定和功能学检测。近年来,免疫比浊法和同位素稀释质谱法等新的检测方法被开发并普及,推动了TAFI在深静脉血栓、心脑血管疾病、出血性疾病和炎症性疾病中的临床应用。文章对TAFI的生理功能进行介绍,并总结TAFI检测技术及其检测原理,梳理TAFI的临床应用价值,旨在更深入地了解TAFI,为血栓性疾病的防治提供参考。
Thrombin-activatable fibrinolysis inhibitor(TAFI)is a single chain glycoprotein with plasma carboxypeptidase-like activity,which is synthesized and secreted mainly by the liver,and it exists in plasma in the form of zymogen.The traditional methods of TAFI deterimination include enzyme-linked immunosorbent assay(ELISA),enzymatic assay and functional assay.In the recent years,new determination methods,such as immunoturbidimetry and isotope dilution mass spectrometry,have been developed and popularized,promoting the clinical application of TAFI in deep vein thrombosis,cardiovascular and cerebrovascular diseases,hemorrhagic diseases and inflammatory diseases.This review introduces the physiological function of TAFI,summarizes the determination technologies and determination principles of TAFI,and it reviews the clinical application value of TAFI,aiming to understand the role of TAFI for thrombotic diseases and provide a reference for prevention and treatment.
作者
崔巍琦
欧心旸
赵春贺
夏薇
曲林琳
CUI Weiqi;OU Xinyang;ZHAO Chunhe;XIA Wei;QU Linlin(Department of Clinical Laboratory,the First Hospital of Jilin University,Changchun 130021,Jilin,China;College of Medical Technology,Beihua University,Jilin 132013,Jilin,China)
出处
《检验医学》
CAS
2024年第10期1021-1026,共6页
Laboratory Medicine
关键词
凝血酶激活的纤溶抑制物
检测
临床应用
实验诊断
Thrombin-activatable fibrinolysis inhibitor
Determination
Clinical application
Experimental diagnosis
